VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
JHX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
JHXJames Hardie Industries plc
$26.15$15.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksJHXFinancials

James Hardie Industries plc (JHX) Income Statement

26Y historyFree accessUpdated daily

Revenue accelerated 63.9% year-over-year to $1.5B in 2027Q1, but gross margin contracted to 37.2% from 40.9% in 2024Q4, and SG&A grew 89% year-over-year, indicating cost pressures that may challenge profitability.

Income StatementBalance SheetCash FlowRatios

JHX Income Statement

Annual statement

JHX Income Statement

James Hardie Industries plc (JHX) annual income statement — 26-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMMar'26Mar'25Mar'24Mar'23Mar'22Mar'21Mar'20Mar'19Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12Mar'11Mar'10Mar'09Mar'08Mar'07Mar'06Mar'05Mar'04Mar'03Mar'02Mar'01
Sales/Revenue5.41B4.84B3.88B3.94B3.78B3.61B2.91B2.61B2.51B2.05B1.92B1.73B1.66B1.49B1.32B1.24B1.17B1.12B1.2B1.47B1.54B1.49B1.21B981.9M803.7M606.9M526.3M
Revenue Growth %42.93%24.71%-1.49%4.21%4.49%24.27%11.58%4%22.01%6.92%11.19%4.3%10.92%13.06%6.77%6.04%3.77%-6.49%-18.12%-4.8%3.65%22.98%23.27%22.17%32.43%15.31%-
Cost of Goods Sold3.47B3.11B2.37B2.35B2.47B2.3B1.86B1.67B1.68B1.32B1.25B1.1B1.08B987.4M902M830.5M775.1M708.5M813.8M938.8M969.9M937.7M784M623M501.9M401.6M0
COGS % of Revenue-64.23%61.19%59.65%65.26%63.66%63.84%64.18%66.85%64.46%64.89%63.42%65.07%66.1%68.27%67.11%66.42%63%67.67%63.92%62.86%63%64.77%63.45%62.45%66.17%-
Gross Profit1.94B1.73B1.5B1.59B1.31B1.31B1.05B933.7M831M730.2M674.7M632.2M578.8M506.4M419.3M407M391.9M416.1M388.8M530M573M550.8M426.4M358.9M301.8M205.3M0
Gross Margin %35.88%35.77%38.81%40.35%34.74%36.34%36.16%35.82%33.15%35.54%35.11%36.58%34.93%33.9%31.73%32.89%33.58%37%32.33%36.08%37.14%37%35.23%36.55%37.55%33.83%-
Gross Profit Growth %-14.92%-5.25%21.07%-0.11%24.89%12.64%12.36%13.8%8.23%6.72%9.23%14.3%20.77%3.02%3.85%-5.82%7.02%-26.64%-7.5%4.03%29.17%18.81%18.92%47%--
Operating Expenses1.22B1.28B849.1M821M570.6M630.9M578.9M591.2M479.4M501M281.5M278.2M243.8M453.3M389.8M251.5M287.2M437.1M215.2M566.6M659.6M594.29M230.2M186.7M170.2M158.4M485.8M
OpEx % of Revenue-26.51%21.9%20.86%15.11%17.45%19.9%22.68%19.13%24.39%14.65%16.1%14.71%30.35%29.5%20.32%24.61%38.87%17.89%38.58%42.75%39.93%19.02%19.01%21.18%26.1%92.3%
Selling, General & Admin1.09B946.4M596.2M602.2M494M461.2M389.6M415.8M403.6M311.3M291.6M254.2M245.5M224.4M218.6M191M173.4M185.8M208.8M228.2M214.6M210.6M174.5M162M153.1M116.2M0
SG&A % of Revenue-19.57%15.38%15.3%13.08%12.76%13.39%15.95%16.1%15.15%15.17%14.71%14.82%15.02%16.54%15.43%14.86%16.52%17.36%15.54%13.91%14.15%14.42%16.5%19.05%19.15%-
Research & Development64M60.7M48.5M47M39.6M38M34.3M32.8M37.9M33.3M30.3M29.5M31.7M33.1M37.2M30.4M28M27.1M23.8M27.3M25.9M28.7M21.6M22.6M18.1M14.1M0
R&D % of Revenue-1.26%1.25%1.19%1.05%1.05%1.18%1.26%1.51%1.62%1.58%1.71%1.91%2.22%2.82%2.46%2.4%2.41%1.98%1.86%1.68%1.93%1.78%2.3%2.25%2.32%-
Other Operating Expenses2.5M274.9M204.4M171.8M37M131.7M155M142.6M37.9M156.4M-40.4M-5.5M-33.4M195.8M134M30.1M85.8M224.2M-17.4M311.1M419.1M354.99M34.1M2.1M-1M28.1M485.8M
Operating Income720.4M447.6M655.9M767.4M741.4M682.6M472.8M342.5M351.6M229.2M393.2M354M335M53.1M29.5M155.5M104.7M-21M173.6M-36.6M-86.6M-43.49M196.2M172.2M131.6M46.9M40.5M
Operating Margin %13.31%9.26%16.92%19.5%19.63%18.88%16.25%13.14%14.03%11.16%20.46%20.48%20.22%3.55%2.23%12.57%8.97%-1.87%14.44%-2.49%-5.61%-2.92%16.21%17.54%16.37%7.73%7.7%
Operating Income Growth %--31.76%-14.53%3.51%8.61%44.37%38.04%-2.59%53.4%-41.71%11.07%5.67%530.89%80%-81.03%48.52%598.57%-112.1%574.32%57.74%-99.13%-122.17%13.94%30.85%180.6%15.8%-
EBITDA1.33B678.7M872.1M952.4M914M844.4M607.8M474M471M321.2M476.4M433.8M405.9M114.5M90.7M220.7M167.6M40.7M230M19.9M-35.9M1.81M232.5M208.6M160.3M86.8M61.1M
EBITDA Margin %24.51%14.03%22.49%24.2%24.2%23.36%20.9%18.18%18.79%15.63%24.79%25.1%24.5%7.66%6.86%17.83%14.36%3.62%19.13%1.35%-2.33%0.12%19.21%21.24%19.95%14.3%11.61%
EBITDA Growth %69.59%-22.18%-8.43%4.2%8.24%38.93%28.23%0.64%46.64%-32.58%9.82%6.87%254.5%26.24%-58.9%31.68%311.79%-82.3%1055.78%155.43%-2083.43%-99.22%11.46%30.13%84.68%42.06%-
D&A (Non-Cash Add-back)605.8M231.1M216.2M185M172.6M161.8M135M131.5M119.4M92M83.2M79.8M70.9M61.4M61.2M65.2M62.9M61.7M56.4M56.5M50.7M45.3M36.3M36.4M28.7M39.9M20.6M
EBIT467.6M437.8M686.4M791.2M760.5M682.4M459.8M342.4M350.7M207.2M395.5M357.1M332.4M59.1M39.2M162.3M105.6M-11M167M-24.4M-86.6M-43.49M196.2M172.2M130.6M75M40.5M
Net Interest Income-193.3M-231.1M-10.3M-15.3M-30.7M-39.3M-47.8M-54.4M-50.1M-29.5M-27.5M-25.6M-7.5M-1.1M2.4M-7.4M-4.4M-4M-3M1.1M0000000
Interest Income0030.7M21.1M6.3M1M700K3.1M4.1M3.4M1M1M2.3M3.4M7.9M3.8M4.6M3.7M8.2M12.2M5.5M7M2.2M0000
Interest Expense193.3M231.1M41M36.4M37M40.3M48.5M57.5M54.2M32.9M28.5M26.6M9.8M4.5M5.5M11.2M9M7.7M11.2M11.1M12M7.2M7.3M0000
Other Income/Expense-446.1M-240.9M-10.5M-12.6M-17.9M-39.5M-60.8M-54.5M-51M-54.9M-26.2M-23.5M-12.4M1.5M4.2M-4.4M-8.1M2.3M-17.8M1.1M-6.5M-391.61M-6.4M-6.5M-19.2M-16.4M-11.6M
Pretax Income274.3M206.7M645.4M754.8M723.5M643.1M412M288M300.6M174.3M367M330.5M322.6M54.6M33.7M151.1M96.6M-18.7M155.8M-35.5M-93.1M-435.1M189.8M165.7M112.4M30.5M28.9M
Pretax Margin %5.07%4.27%16.64%19.18%19.15%17.79%14.16%11.05%11.99%8.48%19.1%19.12%19.47%3.66%2.55%12.21%8.28%-1.66%12.96%-2.42%-6.03%-29.23%15.68%16.88%13.99%5.03%5.49%
Income Tax128.6M102.7M221.4M244.6M211.5M184M149.2M46.5M71.8M28.2M90.5M86.1M31.3M-44.9M-11.8M-453.2M443.6M66.2M19.5M36.1M-243.9M71.6M61.9M40.4M27M3.9M-600K
Effective Tax Rate %46.88%49.69%34.3%32.41%29.23%28.61%36.21%16.15%23.89%16.18%24.66%26.05%9.7%-82.23%-35.01%-299.93%459.21%-354.01%12.52%-101.69%261.98%-16.46%32.61%24.38%24.02%12.79%-2.08%
Net Income145.7M104M424M510.2M512M459.1M262.8M241.5M228.8M146.1M276.5M244.4M291.3M99.5M45.5M604.3M-347M-84.9M136.3M-71.6M151.7M-506.7M126.9M129.6M170.5M29.3M38.6M
Net Margin %2.69%2.15%10.93%12.96%13.56%12.7%9.04%9.26%9.13%7.11%14.39%14.14%17.58%6.66%3.44%48.83%-29.73%-7.55%11.33%-4.87%9.83%-34.04%10.48%13.2%21.21%4.83%7.33%
Net Income Growth %-56.02%-75.47%-16.9%-0.35%11.52%74.7%8.82%5.55%56.61%-47.16%13.13%-16.1%192.76%118.68%-92.47%274.15%-308.72%-162.29%290.36%-147.2%129.94%-499.29%-2.08%-23.99%481.91%-24.09%-
Net Income (Continuing)145.7M104M424M510.2M512M459.1M262.8M241.5M228.8M146.1M276.5M244.4M291.3M99.5M45.5M604.3M-347M-84.9M136.3M-71.6M150.8M-506.7M127.9M125.3M85.4M26.6M29.5M
Discontinued Operations000000000000000000000000000
Minority Interest000000000000000000000000000
EPS (Diluted)0.250.190.981.161.151.030.590.540.520.330.620.550.650.220.101.38-0.80-0.200.31-0.160.33-1.100.280.280.370.070.09
EPS Growth %-67.23%-80.61%-15.52%0.87%11.65%74.58%9.26%3.85%57.58%-46.77%12.73%-15.38%195.45%120%-92.75%272.5%-300%-164.52%293.75%-148.48%130%-492.86%0%-24.32%428.57%-22.22%-
EPS (Basic)-0.190.981.161.151.030.600.550.520.330.620.550.650.220.101.39-0.80-0.200.32-0.160.33-1.100.280.280.370.070.09
Diluted Shares Outstanding584.3M545.5M432.1M439.6M445.6M445.9M445.4M444.1M443M442.3M443.9M447.2M446.4M444.6M440.6M437.9M436.39M432.7M434.5M455M466.4M461.7M461M461.4M459.4M440.4M409.6M
Basic Shares Outstanding580.3M541.8M430.8M438.4M445.1M444.9M443.7M442.6M441.9M441.2M442.7M445.3M445M442.6M439.2M436.2M436.39M432.7M432.3M455M464.6M461.7M458.9M458.1M456.7M438.4M409.6M
Dividend Payout Ratio----25.31%105.42%-65.67%75.22%121.49%63.94%100.86%133.92%200.1%414.29%2.88%--25.39%-27.75%-10.8%17.67%20.12%69.28%-

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Revenue growth sustainability and margin volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2027Q1)

Revenue Surge Amidst Volatility

JHX revenue jumped 63.9% year-over-year in 2027Q1 to $1.5B, according to the latest quarterly report, marking a sharp acceleration from prior quarters and suggesting strong demand or pricing power.

The 63.9% revenue growth in 2027Q1 is a dramatic acceleration from the -9.3% decline in 2026Q1, indicating a potential inflection in end-market demand or successful pricing initiatives. However, this growth follows a period of contraction in fiscal 2025, so investors should assess whether this is a one-time surge or a sustainable trend. The sequential increase from $1.4B in 2026Q4 to $1.5B in 2027Q1 also suggests momentum, but the underlying drivers—volume vs. price—are not disclosed, warranting further investigation.

Gross Margin Resilience Under Pressure

Gross margin contracted from 40.9% in 2024Q4 to 37.2% in 2027Q1, as reported in financial statements, reflecting cost pressures or mix shifts that may challenge profitability.

The gross margin has declined by 370 basis points over the past five quarters, from 40.9% to 37.2%, despite revenue growth. This suggests that input costs or product mix are eroding pricing power, which could be a structural issue if not offset by operational efficiencies. Compared to peers like Trex (39.2%) and Masco (35.5%), JHX's gross margin remains competitive, but the downward trend is concerning and may indicate increased competition or raw material inflation.

Operating Leverage Shows Mixed Signals

Operating income scaled to $217.7M in 2027Q1, a 30.5% increase from the prior quarter, but operating margin at 14.8% remains below the 21.6% peak in 2025Q3, per SEC filings.

While operating income grew significantly in absolute terms, the operating margin has not recovered to the levels seen in 2025Q3 (21.6%). This suggests that SG&A and R&D expenses are growing faster than gross profit, limiting operating leverage. The 2027Q1 SG&A of $295.4M is up 89% from the year-ago quarter, outpacing revenue growth, which may indicate increased investment in sales or administrative infrastructure. Investors should monitor whether these expenses translate into sustained revenue growth or compress margins further.

Earnings Volatility Raises Quality Concerns

Net income swung from a -$55.8M loss in 2026Q2 to $104.3M profit in 2027Q1, with EPS fluctuating between -$0.10 and $0.36, based on reported figures, indicating non-operating items or tax effects.

The extreme volatility in net income and EPS, including a loss in 2026Q2, suggests that reported earnings are influenced by one-time items, tax adjustments, or impairments that are not part of core operations. The net margin of 7.1% in 2027Q1 is below the 15.7% seen in 2025Q1, and the negative EPS in 2026Q2 highlights the unpredictability of earnings. Stock-based compensation is relatively small (max $12M), so the swings are likely due to operational or non-operating factors that warrant deeper investigation.

Cost Structure Under Scrutiny

COGS as a percentage of revenue rose to 62.8% in 2027Q1 from 59.1% in 2024Q4, while SG&A grew 89% year-over-year, as per financial statements, signaling cost inflation and expense discipline challenges.

The increase in COGS ratio indicates that input costs are rising faster than pricing, compressing gross margins. Simultaneously, SG&A expenses have grown disproportionately, with 2027Q1 SG&A of $295.4M versus $156.1M in 2026Q1, a 89% increase. This suggests that management is investing heavily in sales and marketing, possibly to support growth, but it is eroding operating leverage. R&D spending has remained relatively stable, so the primary cost pressures are in COGS and SG&A, which investors should monitor for efficiency improvements.

2027Q1 Marks a Turning Point

The 2027Q1 quarter stands out as a pivotal inflection, with revenue surging to $1.5B and operating income reaching $217.7M, according to the latest income statement, reversing a prior downtrend.

After a period of declining revenue from 2024Q4 through 2026Q1, 2027Q1 shows a dramatic rebound, with revenue up 63.9% year-over-year and operating income up from $138.6M to $217.7M. This inflection may be driven by new product launches, market share gains, or a cyclical recovery in construction demand. However, the sustainability of this growth is uncertain, as the prior quarters showed significant volatility, and the gross margin has not fully recovered, suggesting that the growth may be coming at a cost.

Growth Sustainability and Margin Risks

The 63.9% revenue surge in 2027Q1 may be unsustainable, as gross margins have contracted and SG&A costs have ballooned, according to reported data, potentially signaling a short-term spike.

Short-sellers might argue that the revenue growth is not translating into proportional profit growth, with net margin at 7.1% versus 15.7% in 2025Q1. The gross margin decline and SG&A escalation suggest that the company is buying growth, which could compress margins further if revenue growth slows. Additionally, the historical volatility in earnings, including a loss in 2026Q2, indicates that the business is subject to significant swings, making the current profitability level unreliable. Investors should question whether the 2027Q1 performance is a new baseline or an anomaly.

JHX — Frequently Asked Questions

Quick answers to the most common questions about buying JHX stock.

What was James Hardie Industries plc's (JHX) revenue in 2026?

For fiscal year 2026, James Hardie Industries plc (JHX) reported total revenue of $4.84B. This represents a 818.8% increase compared to $526.3M in 2001.

Is James Hardie Industries plc (JHX) profitable?

James Hardie Industries plc (JHX) is profitable, generating $104.0M in net income for the fiscal year ending 2026 with a net profit margin of 2.2%.

What is James Hardie Industries plc's operating profit margin?

James Hardie Industries plc (JHX) reported an operating income of $447.6M, resulting in an operating profit margin of 9.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is James Hardie Industries plc's gross profit and gross margin?

James Hardie Industries plc (JHX) generated $1.73B in gross profit for the year, representing a gross profit margin of 35.8%. This demonstrates the company's core pricing power and production efficiency.